Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China flag China · Delayed Price · Currency is CNY
21.31
+0.07 (0.33%)
Apr 29, 2026, 3:04 PM CST

SHE:300702 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
571.87512.25592.87426.15476.98476.75
Trading Asset Securities
0.630.8---72.94
Cash & Short-Term Investments
572.5513.05592.87426.15476.98549.7
Cash Growth
4.35%-13.46%39.12%-10.66%-13.23%-58.80%
Accounts Receivable
707.25719.17594.26583.07455.15489.08
Other Receivables
2.642.261.985.016.46.22
Receivables
709.89721.43596.24588.09461.56495.3
Inventory
1,5941,7141,8811,8902,0171,599
Other Current Assets
44.263.9259.3947.3861.95188.71
Total Current Assets
2,9203,0123,1292,9513,0182,832
Property, Plant & Equipment
2,8682,9162,8212,7932,8102,465
Long-Term Investments
103.6199.718889.8587.5778.61
Other Intangible Assets
449.96453.54408.77374.8366.82374.75
Long-Term Deferred Tax Assets
11.7713.6815.088.2515.8615
Long-Term Deferred Charges
39.1143.1961.3577.5760.543.55
Other Long-Term Assets
47.8651.0254.8943.3857.2731.49
Total Assets
6,4406,5896,5796,3386,4165,801
Accounts Payable
716.04867.35961.08803.061,3581,173
Accrued Expenses
77.19125.71161.08118.32140.45138.02
Short-Term Debt
1,4631,4351,6081,5251,066422.96
Current Portion of Long-Term Debt
105.74108.188448.7446.579.05
Current Portion of Leases
--9.448.969.2914.27
Current Income Taxes Payable
21.8727.770.2317.32--
Current Unearned Revenue
30.5223.6323.5418.1641.1346.94
Other Current Liabilities
41.4838.0716.1623.788.593.56
Total Current Liabilities
2,4562,6262,8632,5632,6701,877
Long-Term Debt
186.09199.6102.69187.36143.297.12
Long-Term Leases
24.3127.2932.3328.7821.8723.85
Long-Term Unearned Revenue
66.2866.6467.9564.4169.1970.92
Long-Term Deferred Tax Liabilities
13.4913.348.891.499.3813.9
Other Long-Term Liabilities
12.1816.775.585.0778.15
Total Liabilities
2,7582,9503,0812,8502,9212,091
Common Stock
347.98347.98347.98347.98347.98347.98
Additional Paid-In Capital
1,4401,4401,4111,4561,4901,493
Retained Earnings
1,9451,9031,7811,7421,7151,869
Treasury Stock
-44.45-44.69-34.95-58-58-
Comprehensive Income & Other
-6.66-6.66-6.66-0.14-0.14-0.14
Shareholders' Equity
3,6823,6403,4983,4883,4953,709
Total Liabilities & Equity
6,4406,5896,5796,3386,4165,801
Total Debt
1,7791,7701,8361,7991,287637.26
Net Cash (Debt)
-1,207-1,257-1,243-1,373-810.23-87.56
Net Cash Per Share
-3.54-3.69-3.56-4.01-2.32-0.25
Filing Date Shares Outstanding
348.11310.99343.93343.93347.98347.98
Total Common Shares Outstanding
348.11310.99343.93345.57347.98347.98
Working Capital
464.37386.02265.8388.06347.65954.76
Book Value Per Share
10.5811.7010.1710.0910.0410.66
Tangible Book Value
3,2323,1863,0893,1133,1283,334
Tangible Book Value Per Share
9.2810.248.989.018.999.58
Buildings
--1,1181,0561,000798.58
Machinery
--2,8732,6462,3161,831
Construction In Progress
--327.76298.59439.07556.36
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.